Viohalco S.A. is listed on Euronext Brussels (VIO) and the Athens Stock Exchange (BIO).
Viohalco companies generate a consolidated annual revenue of more than EUR 7 billion (2022) and have main production facilities in 8 countries and sales in 95 countries worldwide.
Products distributed in
Focused on technology
Main manufacturing sites in
Strong commercial network
across 18 countries
Diversified portfolio of businesses serving dynamic markets
The Viohalco companies are committed to sustainable manufacturing of high-quality, innovative products and solutions for dynamic and promising markets: